SCHEMBL30977417

SCHEMBL30977417

COc1ccc(CN(Cc2ccc(OC)cc2)c2nc(OC)c(CCC(=O)O)c(OC)n2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.48
TSHR P16473 1/20 0.48
FFAR1 O14842 3/20 0.48
LMNA P02545 3/20 0.43
ATM Q13315 1/20 0.43
TLR7 Q9NYK1 1/20 0.42
LDHA P00338 1/20 0.41
HDAC6 Q9UBN7 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MAPT P10636 3/20 0.40
F2RL1 P55085 1/20 0.40
ACHE P22303 1/20 0.40
ALDH1A1 P00352 4/20 0.40
POLB P06746 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
ALOX5 P09917 1/20 0.40
PIK3CA P42336 1/20 0.40
FFAR4 Q5NUL3 1/20 0.40
KDM4E B2RXH2 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31736371 0.90 MTNR1A (0.41) USP2TSHRLMNAMAPTF2RL1
SCHEMBL31736504 0.86 MAPT (0.42) USP2TSHRLMNAL3MBTL1MAPT
SCHEMBL31737034 0.83 FFAR1 (0.47) USP2TSHRFFAR1LMNAATM
SCHEMBL30977515 0.82 PRUNE1 (0.45) USP2TSHRLMNAMAPTALDH1A1
SCHEMBL30977477 0.80 PIK3CA (0.44) USP2TSHRLMNAMAPTALDH1A1
SCHEMBL26977840 0.79 LMNA (0.41) USP2TSHRLMNAL3MBTL1MAPT
SCHEMBL26977735 0.78 LMNA (0.48) USP2TSHRLMNAMAPTACHE
SCHEMBL30977414 0.78 LMNA (0.43) USP2TSHRLMNAMAPTALDH1A1
SCHEMBL26978069 0.76 LMNA (0.48) USP2TSHRLMNAMAPTALDH1A1
SCHEMBL12935065 0.76 LMNA (0.48) USP2TSHRLMNAMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025243044-A1 COMPOUNDS Pheno Therapeutics Limited (GB) 2025-11-27 WO disclosed
EP-4619402-A1 GPR17 MODULATORS AND USES THEREOF Myrobalan Therapeutics, Inc. (US) 2025-09-24 EP disclosed
CN-119613397-A N-heteroaromatic ring-3-sulfonamide compounds and use thereof for preparing GPR17 receptor inhibitors 迈巴制药(南京)有限公司 2025-03-14 CN disclosed
WO-2024104462-A1 GPR17 MODULATORS AND USES THEREOF MYROBALAN THERAPEUTICS NANJING CO. LTD (CN) 2024-05-23 WO disclosed